Stay updated on Eli Lilly and Company Press Releases

Sign up to get notified when there's something new on the Eli Lilly and Company Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Eli Lilly and Company Press Releases page

  1. Check
    yesterday
    Change Detected
    Summary
    Added three press releases: Zepbound pricing and KwikPen availability; Omvoh Crohn's disease data; and TOGETHER-PsO efficacy data for Taltz and Zepbound. Removed three older items including the Q4 2025 results date, Breakthrough Therapy designation for sofetabart mipitecan, and the NVIDIA–Lilly AI Lab announcement.
    Difference
    8%
    Check dated 2026-02-23T17:49:41.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    New press releases were added covering Lilly's participation in TD Cowen's 46th Annual Health Care Conference, the USOPC Team USA Athlete Recovery Program partnership, and other updates from early 2026. Older items such as the TOGETHER-PsA results, the Ventyx acquisition, ATTAIN-MAINTAIN results, and a J.P. Morgan conference notice were removed.
    Difference
    8%
    Check dated 2026-02-16T15:16:42.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A new press release entry dated 02/04/2026 announcing Q4 2025 financial results and 2026 guidance was added to the Press Releases page, aligning with its purpose of presenting corporate news. An older Inluriyo/imlunestrant update entry from 12/12/2025 was removed.
    Difference
    2%
    Check dated 2026-02-09T11:48:11.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added two new press releases: 'Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility' (01/30/2026) and 'Lilly Responds to American Hospital Association Letter to HRSA About 340B Program Changes' (01/29/2026).
    Difference
    23%
    Check dated 2026-02-02T09:09:01.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    New press releases were added for the Q4 2025 results date, sofetabart mipitecan Breakthrough Therapy designation, and the NVIDIA–Lilly AI Lab. Older items such as the Adverum tender offer update, Jaypirca data, and the Q1 2026 dividend were removed.
    Difference
    9%
    Check dated 2026-01-26T07:16:20.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    New press releases were added about the Taltz/Zepbound Phase 3b trial results and Lilly's acquisition of Ventyx Biosciences. A board member announcement for Carolyn Bertozzi and a Jaypirca BRUIN CLL-314 trial result have been removed.
    Difference
    8%
    Check dated 2026-01-12T04:51:51.000Z thumbnail image

Stay in the know with updates to Eli Lilly and Company Press Releases

Enter your email address, and we'll notify you when there's something new on the Eli Lilly and Company Press Releases page.